June 17, 2024 — Elutia Inc., a pioneer in drug-eluting biomatrix products, today announced that its Antibiotic-Eluting BioEnvelope, EluPro (referred to as CanGaroo during development), has received clearance from the U.S. Food and Drug Administration (FDA).

June 17, 2024 — aycan, a recognized leader in medical imaging, announced today a reseller and technology partnership with AI4MedImaging, a company that specializes in applying artificial intelligence (AI) to medical imaging.

aycan launched its official partnership with AI4MedImaging this week by offering their groundbreaking AI4CMR solution, a Software as a Medical Device (SaMD) that aims to automate the interpretation of cardiac magnetic resonance imaging (CMR) using AI.

June 14, 2024 — Until now, known risk factors for cardiac arrest have been limited to cardiovascular conditions such as hypertension and high cholesterol. Research published June 11 identifies a range of new factors — for instance, single marital status and alcohol and substance abuse — that also are highly associated with out-of-hospital cardiac arrest (OHCA). 

June 14, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT(Positron Emission Tomography/Computed Tomography) imaging systems and clinical services, announced its membership in the national alliance “Cardiac PET Industry Coalition” (CPIC), an organization at the forefront of quality of patient care, advocacy and innovation to advance the field of cardiovascular PET imaging.

June 13, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest innovation in cardiac surgery, the Avalus Ultra valve.

June 13, 2024 — Xeltis, a leading developer of transformative implants that enable the natural creation of living and long-lasting vessels, announces that it has gained approval from the US Food and Drug Administration (FDA) for an Investigational Device Exemption (IDE) submission to begin enrolling patients into a pivotal study for aXess.

June 13, 2024 — Visura Technologies, Inc., a privately owned medical device company, has announced the TEECADE mini, an initiative for the next innovation in transesophageal echocardiography (TEE) imaging technology.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now